Jun Wang

Company: GemPharmatech

Job title: Director of Scientific Engagement

Seminars:

Mouse Models to Study Mechanisms of Drug Resistance in Immunotherapies & ADCs 11:30 am

Establishment and validation of in vivo and in vitro trastuzumab deruxtecan (Enhertu)-induced resistant tumor models Creation of syngeneic and engineered models of primary and acquired resistance to anti-PD1 therapies (e.g., CT26-PD1-R and B2M-KO models) Other humanized and syngeneic mouse models tailored for immune checkpoint inhibitors, ADCs, and combination of therapiesRead more

day: Day Two